References
- Brown D. W., Nakashima T. T., Rabenstein D. L. Simplification and assignment of carbon‐13 spectra with spin‐echo Fourier transform techniques. Journal of Magnetic Resonance 1981; 45: 302–314
- Burk R. F. Trace Elements in Human Health and Disease, A. Prasad. Academic Press, New York 1976; Vol. 2: 105–133
- Byard L. J. Trimethylselenide. A urinary metabolite of selenite. Archives of Biochemistry and Biophysics 1969; 130: 556–560
- Combs G. F., Combs S. B. The Role of Selenium in Nutrition. Academic Press, Orlando 1986
- Kamigata N., Takata M., Matsuyama H., Kobayashi M. Novel ring opening reaction of 2‐aryl‐1,2‐benzisoselenazo‐3(2H)‐one with thiols. Heterocycles 1986; 24: 3027–3030
- Kuhl P., Borbe H. O., Römer A., Fischer H., Parnham M. J. Selective inhibition of leukotriene B4 formation by ebselen: a novel approach to antiinflammatory therapy. Agents and Actions 1985; 17: 366–367
- Kuhl P., Borbe H. O., Fischer H., Römer A., Safayhi H. Ebselen reduces the formation of LTB4 in human and porcine leucocytes by isomerisation to its 5S,12R‐6‐trans‐isomer. Prostaglandins 1986; 31: 1029–1048
- Lambert C., Cantineau R., Christiaens L., Biederman J., Dereu N. Synthesis and spectral characterization of the metabolites of a new organo‐selenium drug: Ebselen. Bulletin de la Sociètè Chimique de Belgique 1987; 96: 383–389
- Müller A., Gabriel H., Sies H., Terlinden R., Fischer H., Römer A. A novel biologically active selenoorganic compound. VII. Biotransformation of ebselen in perfused rat liver. Biochemical Pharmacology 1988; 37(6)1103–1109
- Palmer I. S., Gunsalus R. P., Halverson A. W., Olson O. E. Trimethylselenonium ions as a general excretory product from selenium metabolism in the rat. Biochimica et Biophysica Acta 1970; 108: 260–266
- Schalkwijk J., van DEN Berg W. B., van DEN Putte B. A., Joosten L. A. B. An experimental model for hydrogen peroxide‐induced tissue damage effects of a single inflammatory mediator on (peri) articular tissues. Arthritis and Rheumatism 1986; 29: 532–538
- van Caneghem P. Influences comperatives de differentes substances sèlenièes et soufrèes sur ia fragilitè des lysosomes et des mitochondries in vitro. Biochemical Pharmacology 1974; 23: 3491–3500
- Wendel A., Tiegs G. A novel biologically active seleno‐organic compound. VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin‐induced hepatitis in mice. Biochemical Pharmacology 1986; 35: 2115–2118